The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration

Blood

Volumn 113, Issue 15, 2009, Pages 3443-3452

  Porcellini, Simona ^a   Alberici, Luca ^a   Gubinelli, Francesco ^a   Lupo, Rossella ^a   Olgiati, Clelia ^a   Rizzardi, Gian Paolo ^a   Bovolenta, Chiara ^a  

^a MOLMED S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD34 ANTIGEN; CHIMERIC PROTEIN; F12 VIF PROTEIN; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA INTEGRATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LIFE CYCLE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STEM CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE;

EID: 65349148559     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-06-158790     Document Type: Article

References (37)

1. Strayer DS, Akkina R, Bunnell BA, et al. Current status of gene therapy strategies to treat HIV/ AIDS. MolTher. 2005;11:823-842.
2. von Laer D, Hasselmann S, Hasselmann K. Gene therapy for HIV infection: what does it need to make it work? J Gene Med. 2006;8:658-667.
3. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous ret- roelements. Annu Rev Immunol. 2008;26:317-353.
4. Carlini F, Federico M, Equestre M, et al. Sequence analysis of an HIV-1 proviral DNAfrom a non producer chronically infected HUT-78 cellular clone: sequence analysis of HIV-1 from a non producer clone. J Viral Disease. 1992;1:40-55.
5. Vallanti G, Lupo R, Federico M, Mavilio F, Bovolenta C. T lymphocytes transduced with a lentiviral vector expressing F12-vif are protected from HIV-1 infection in an APOBEC3G-indepen- dent manner. Mol Ther. 2005;12:697-706.
6. Henriet S, Richer D, Bernacchi S, et al. Cooperative and specific binding of Vif to the 5′ region of HIV-1 genomic RNA. J Mol Biol. 2005;354:55-72.
7. Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 2004;18:2867-2872.
8. Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif- Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 2004;18:2861-2866.
9. Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins. PLoS ONE. 2008;3:e3963.
10. Pery E, Rajendran KS, Brazier AJ, Gabuzda D. Regulation of APOBEC3 proteins by a novel YxxL motif in human immunodeficiency virus type 1 and simian immunodeficiency virus (SIVagm) Vif. J Virol. 2009;83:2374-2381.
11. Xiao Z, Ehrlich E, Yu Y, et al. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc- binding domain-stabilized hydrophobic interface in Vif. Virology. 2006;349:290-299.
12. Mehle A, Thomas ER, Rajendran KS, Gabuzda D. Azinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem. 2006;281: 17259-17265.
13. Luo K, Xiao Z, Ehrlich E, et al. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci USA. 2005;102:11444-11449.
14. Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif- Cul5-SCF complex. Science. 2003;302:1056-1060.
15. Burke B, Sumner S, Maitland N, Lewis CE. Mac- rophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol. 2002;72: 417-428.
16. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272: 263-267.
17. Corbeau P, Kraus G, Wong-Staal F. Transduction of human macrophages using a stable HIV-1/HIV- 2-derived gene delivery system. Gene Ther. 1998;5:99-104.
18. Schroers R, Sinha I, Segall H, et al. Transduction of human PBMC-derived dendritic cells and mac- rophages by an HIV-1-based lentiviral vector sys- tem.Mol Ther. 2000;1:171-179.
19. Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol. 2003;74:635-641.
20. Banerjea A, Li MJ, Remling L, Rossi J, Akkina R. Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages. AIDS Res Ther. 2004;1:2.
21. Anderson JS, Bandi S, Kaufman DS, Akkina R. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology. 2006;3:24.
22. Anderson J, Akkina R. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Ther. 2007;14:1287-1297.
23. Taylor JA, Vojtech L, Bahner I, et al. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Mol Ther. 2008;16:46-51.
24. Young J, Tang Z, Yu Q, Yu D, Wu Y. Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis. Retrovirology. 2008;5: 36.
25. Folks T, Benn S, Rabson A, et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A. 1985;82:4539-4543.
26. Clouse KA, Powell D, Washington I, et al. Monokine regulation of human immunodeficiency vi- rus-1 expression in a chronically infected human T cell clone. J Immunol. 1989;142:431-438.
27. Ory DS, Neugeboren BA, Mulligan RC. Astable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A. 1996;93: 11400-11406.
28. Vicenzi E, Panina-Bodignon P, Vallanti G, Di Lucia P, Poli G. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells. J Leukoc Biol. 2002;72:913-920.
29. Bovolenta C, Pilotti E, Mauri M, et al. Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1. J Immunol. 2002;169:4443-4449.
30. Goncalves J, Santa-Marta M. HIV-1 Vif and APOBEC3G: multiple roads to one goal. Retrovi- rology. 2004;1:28.
31. Stopak K, de Noronha C, Yonemoto W, Greene WC. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell. 2003;12:591-601.
32. Akari H, Fujita M, Kao S, et al. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleo- capsid processing site. J Biol Chem. 2004;279:12355-12362.
33. Cancio R, Spadari S, Maga G. Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass. Biochem J. 2004;383: 475-482.
34. Henriet S, Sinck L, Bec G, Gorelick RJ, Marquet R, Paillart JC. Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Nucleic Acids Res. 2007;35:5141-5153.
35. Carr JM, Coolen C, Davis AJ, Burrell CJ, Li P. Human immunodeficiency virus 1 (HIV-1) virion in- fectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription. Virology. 2008;372:147-156.
36. Lv W, Liu Z, Jin H, Yu X, Zhang L, Zhang L. Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation. Org Biomol Chem. 2007;5: 617-626.
37. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31:3784-3788.